Related Experiment Video
Updated: Nov 26, 2025
Calvarial Model of Bone Augmentation in Rabbit for Assessment of Bone Growth and Neovascularization in Bone Substitution Materials
Published on: August 13, 2019
microRNAs in inflammatory alveolar bone defect: A review
Yun Yuan1,2,3, Hongming Zhang1,2,3, Hui Huang1,2,3
1Department of Prosthodontics, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
Inflammatory alveolar bone defects are caused by periodontal pathogens, are one of the most common oral diseases in the clinic, and are characterized by periodontal support tissue damage. MicroRNAs (miRNAs) can participate in a variety of inflammatory lesions and modulate bone metabolism through the posttranscriptional regulation of target genes. In recent years, studies have confirmed that some miRNAs play significant roles in the development of inflammatory alveolar bone defects. Therefore, we reviewed the correlation between miRNAs and inflammatory alveolar bone defects and elucidated the underlying mechanisms to provide new ideas for the prevention and treatment of inflammatory alveolar bone defects.
Insights
MicroRNAs (miRNAs) are involved in inflammatory alveolar bone defects, a common oral disease causing tissue damage. Understanding miRNA mechanisms offers new therapeutic strategies for this condition.
Area of Science:
- Oral biology
- Molecular biology
- Biomedical science
Background:
- Inflammatory alveolar bone defects are common oral diseases caused by periodontal pathogens, leading to periodontal support tissue damage.
- MicroRNAs (miRNAs) are key regulators of gene expression, influencing inflammatory processes and bone metabolism.
- Emerging evidence highlights the significant role of specific miRNAs in the pathogenesis of inflammatory alveolar bone defects.
Purpose of the Study:
- To review the current literature on the correlation between microRNAs and inflammatory alveolar bone defects.
- To elucidate the underlying molecular mechanisms by which miRNAs influence the development of these defects.
- To identify potential miRNA-based therapeutic targets for prevention and treatment.
Main Methods:
- Comprehensive literature search of studies investigating miRNAs in inflammatory alveolar bone defects.
- Analysis of miRNA biogenesis, function, and target gene regulation in the context of bone metabolism.
- Review of experimental evidence linking specific miRNAs to periodontal disease progression and bone loss.
Main Results:
- Several miRNAs have been identified as critical players in the inflammatory pathways and bone remodeling associated with alveolar bone defects.
- miRNAs regulate key genes involved in osteoblast differentiation, osteoclastogenesis, and inflammatory responses.
- Dysregulation of specific miRNAs contributes to the severity and progression of inflammatory alveolar bone defects.
Conclusions:
- MicroRNAs represent a significant regulatory layer in the pathogenesis of inflammatory alveolar bone defects.
- Targeting specific miRNAs holds promise for developing novel diagnostic and therapeutic interventions for periodontal diseases.
- Further research into miRNA-mediated mechanisms can pave the way for innovative treatments to preserve periodontal support tissues.
